Anika Therapeutics, Inc.: 10-Q filed 2013-08-06

Name: Anika Therapeutics, Inc.: 10-Q filed 2013-08-06
Creator: Anika Therapeutics, Inc.

What Anika Therapeutics, Inc. reported in its quarterly report filed 2013-08-06 (fiscal Q2 2013): 42 published measures, 111 facts as tagged in accession 0001157523-13-003914.

This filing

Form: 10-Q (quarterly report)
Filed: 2013-08-06
Fiscal period: fiscal Q2 2013
Accession: 0001157523-13-003914 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Anika Therapeutics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2013-06-30	148,394,650	USD
At 2012-12-31	142,069,051	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2013-06-30	119,433,839	USD
At 2012-12-31	108,925,134	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2013-06-30	54,140,459	USD
At 2012-12-31	44,067,477	USD
At 2012-06-30	37,909,608	USD
At 2011-12-31	35,777,222	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	5,894,892	USD	91
2013-01-01 to 2013-06-30	8,962,894	USD	181
2012-04-01 to 2012-06-30	3,736,868	USD	91
2012-01-01 to 2012-06-30	5,648,987	USD	182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	9,632,926	USD	181
2012-01-01 to 2012-06-30	3,534,789	USD	182

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	109,871	USD	181
2012-01-01 to 2012-06-30	1,145,493	USD	182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	335,471	USD	181
2012-01-01 to 2012-06-30	-252,642	USD	182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	136,914	USD	181
2012-01-01 to 2012-06-30	-1,145,493	USD	182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2013-06-30	54,972,575	USD
At 2012-12-31	46,009,681	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	13,510,573	shares	91
2013-01-01 to 2013-06-30	13,459,049	shares	181
2012-04-01 to 2012-06-30	13,262,023	shares	91
2012-01-01 to 2012-06-30	13,212,424	shares	182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	14,578,927	shares	91
2013-01-01 to 2013-06-30	14,484,978	shares	181
2012-04-01 to 2012-06-30	14,443,794	shares	91
2012-01-01 to 2012-06-30	14,302,439	shares	182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	0.44	USD/shares	91
2013-01-01 to 2013-06-30	0.67	USD/shares	181
2012-04-01 to 2012-06-30	0.28	USD/shares	91
2012-01-01 to 2012-06-30	0.43	USD/shares	182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	0.4	USD/shares	91
2013-01-01 to 2013-06-30	0.62	USD/shares	181
2012-04-01 to 2012-06-30	0.26	USD/shares	91
2012-01-01 to 2012-06-30	0.39	USD/shares	182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	3,467,219	USD	91
2013-01-01 to 2013-06-30	5,371,083	USD	181
2012-04-01 to 2012-06-30	2,347,873	USD	91
2012-01-01 to 2012-06-30	3,447,611	USD	182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2013-06-30	33,846,579	USD
At 2012-12-31	35,112,981	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	788,326	USD	181
2012-01-01 to 2012-06-30	633,073	USD	182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	9,398,492	USD	91
2013-01-01 to 2013-06-30	14,409,916	USD	181
2012-04-01 to 2012-06-30	6,133,870	USD	91
2012-01-01 to 2012-06-30	9,196,930	USD	182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2013-06-30	86,473,938	USD
At 2012-12-31	77,384,490	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2013-06-30	11,701,318	USD
At 2012-12-31	14,452,618	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2013-06-30	2,699,678	USD
At 2012-12-31	2,341,838	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit
At 2013-06-30	8,923,197	USD
At 2013-03-31	8,792,165	USD
At 2012-12-31	9,065,891	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2013-06-30	19,065,386	USD
At 2012-12-31	21,462,481	USD

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2013-06-30	10,357,798	USD
At 2012-12-31	8,283,472	USD

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	3,400,679	USD	91
2013-01-01 to 2013-06-30	7,347,793	USD	181
2012-04-01 to 2012-06-30	4,108,503	USD	91
2012-01-01 to 2012-06-30	7,459,519	USD	182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	1,829,052	USD	91
2013-01-01 to 2013-06-30	3,411,962	USD	181
2012-04-01 to 2012-06-30	1,298,170	USD	91
2012-01-01 to 2012-06-30	2,831,273	USD	182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2013-06-30	14,017,280	shares
At 2012-12-31	13,866,060	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2013-06-30	67,385,076	USD
At 2012-12-31	65,431,424	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2013-06-30	8,800,000	USD
At 2012-12-31	9,600,000	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2013-06-30	51,618,726	USD
At 2012-12-31	52,376,013	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2013-06-30	17,772,147	USD
At 2012-12-31	17,263,032	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2013-06-30	18,996,886	USD
At 2012-12-31	20,334,636	USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2013-06-30	1,264,427	USD
At 2012-12-31	1,541,124	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2013-06-30	4,503,551	USD
At 2012-12-31	5,837,044	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2013-06-30	920,873	USD
At 2012-12-31	1,539,477	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	9,362,111	USD	91
2013-01-01 to 2013-06-30	14,333,977	USD	181
2012-04-01 to 2012-06-30	6,084,741	USD	91
2012-01-01 to 2012-06-30	9,096,598	USD	182

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	6,234,987	USD	91
2013-01-01 to 2013-06-30	8,553,539	USD	181
2012-04-01 to 2012-06-30	2,136,664	USD	91
2012-01-01 to 2012-06-30	4,805,244	USD	182

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	2,270,895	USD	181
2012-01-01 to 2012-06-30	2,182,129	USD	182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2013-04-01 to 2013-06-30	514,425	USD	91
2013-01-01 to 2013-06-30	1,034,408	USD	181
2012-04-01 to 2012-06-30	506,706	USD	91
2012-01-01 to 2012-06-30	1,022,984	USD	182

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	-269,149	USD	181
2012-01-01 to 2012-06-30	14,036	USD	182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	-1,796,522	USD	181
2012-01-01 to 2012-06-30	892,265	USD	182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	2,324,269	USD	181
2012-01-01 to 2012-06-30	3,713,817	USD	182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2013-01-01 to 2013-06-30	878,228	USD	181
2012-01-01 to 2012-06-30	-170,035	USD	182

Inspect the source

Entity: Anika Therapeutics, Inc. / CIK 0000898437
Captured: 2026-09-20T05:04:56.960Z
SEC response SHA-256: f1da3290842851cfa646165073c3c5bf9c06212e35bc3d1892f2be77cae8b535

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000898437.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))